RxDoctor Payments Data

Sabrina Huffman

Family · Princeton, WVNPI 1366720047

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 439 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,867in general payments, 2019–2025

Across 439 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • Lilly USA, LLC$843
  • AbbVie$817
  • AstraZeneca$588
  • GSK$577
  • Boehringer Ingelheim$538
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$6,867100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,867 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide59$74,248
FarxigaDapagliflozin Propanediol31$43,639
MounjaroTirzepatide40$43,457
JardianceEmpagliflozin47$41,369
JanuviaSitagliptin Phosphate42$40,122
Tresiba Flextouch U-100Insulin Degludec29$25,224
EliquisApixaban26$21,751
LinzessLinaclotide17$18,360
KerendiaFinerenone18$17,147
Fiasp FlextouchInsulin Aspart (Niacinamide)11$16,340
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$16,268
Combivent RespimatIpratropium/Albuterol Sulfate14$6,737
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$5,210
SymbicortBudesonide/Formoterol Fumarate14$3,648
Albuterol Sulfate HfaAlbuterol Sulfate90$2,458

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,169$74,24859 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$588$63,55563 claims
Boehringer IngelheimJardiance, Combivent Respimat$538$48,10661 claims
Lilly USA, LLCMounjaro$843$43,45740 claims
MerckJanuvia$292$40,12242 claims
PfizerEliquis$119$21,75126 claims
AbbVieLinzess, Synthroid$817$19,44729 claims
BayerKerendia$247$17,14718 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,507 family providers in West Virginia.

Other family in Princeton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →